The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II trial of durvalumab plus tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma: Final results.
 
Houda Bahig
Honoraria - Amgen
Consulting or Advisory Role - Sanofi
Research Funding - AstraZeneca; Varian Medical Systems
 
Francine Aubin
Consulting or Advisory Role - Bristol-Myers Squibb Canada; Incyte; Merck; Pfizer; Taiho Pharmaceutical
Speakers' Bureau - Amgen; Bristol-Myers Squibb Canada; Merck; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb/Medarex (Inst); Merck (Inst)
 
Phuc Felix Nguyen-Tan
No Relationships to Disclose
 
Denis Soulieres
Honoraria - Adlai Nortye; AstraZeneca; Bristol-Myers Squibb; Eisai; Ipsen; Merck; Novartis; Pfizer
Consulting or Advisory Role - Adlai Nortye; Eisai; Ipsen; Merck; Pfizer
Research Funding - Adlai Nortye (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Brock John Debenham
No Relationships to Disclose
 
Danielle Charpentier
Consulting or Advisory Role - Gilead Sciences; Novartis
Research Funding - Gilead Sciences (Inst); Merck (Inst); Roche (Inst)
 
David A. Palma
Employment - London Health Sciences Centre (LHSC)
Stock and Other Ownership Interests - Need
Consulting or Advisory Role - Need
Patents, Royalties, Other Intellectual Property - US Patent: A Method for Analyzing a Three-Dimensional Computed Tomography Image, United States Patent Application No. 61/896349 (not licensed, no commercial or financial impact)
 
Eric Winquist
Consulting or Advisory Role - Advanced Accelerator Applications; Amgen; Bayer; Eisai; EMD Serono; Ipsen; Merck; Roche
Research Funding - Ayala Pharmaceuticals (Inst); Eisai (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Rahima Jamal
Consulting or Advisory Role - BMS
Research Funding - alkermes (Inst); Astellas Pharma (Inst); BioNTech SE (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Iovance Biotherapeutics (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pacylex (Inst); Pfizer (Inst); Surface Oncology (Inst); VelosBio/Merck (Inst)
 
Khalil Sultanem
No Relationships to Disclose
 
Olivier Ballivy
No Relationships to Disclose
 
Edith Filion
No Relationships to Disclose
 
Tyler Pittman
No Relationships to Disclose
 
Manjula Maganti
No Relationships to Disclose
 
Philip Wong
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb